Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-24 @ 1:00 PM
NCT ID:
NCT01739361
Eligibility Criteria:
Inclusion Criteria:
* Males and Female \>=18 years old
* Admitted to an Intensive Care Unit
* Severe Sepsis
* Detectable plasma cell-free hemoglobin
Exclusion Criteria:
* patients who received acetaminophen in the past 48 hours prior to enrollment
* intolerance or allergy to acetaminophen
* measured AST/ALT \>400 U/L in the 24 hours prior to enrollment
* chronic liver disease defined by a Child-Pugh score \>4
* cannot swallow or have no enteral feeding access
* patients with no detectable cell-free hemoglobin
* patients transitioned to palliative care
* pregnant patients or women of childbearing potential without a documented pregnancy test
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01739361
Study Brief:
Protocol Section:
NCT01739361